HealthCCSng vs Zio XT ECG Monitoring System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

HealthCCSng

by Nano-X AI

Zio XT ECG Monitoring System

by iRhythm Technologies

AI Verdict

HealthCCSng is designed for assessing coronary artery disease risk by quantifying calcification from CT scans, providing a structural snapshot. In contrast, the Zio XT ECG Monitoring System focuses on detecting and diagnosing cardiac arrhythmias through continuous, long-term electrical monitoring using a wearable biosensor. Therefore, while both are cardiology AI tools, they address distinct clinical questions and utilize different diagnostic modalities, making them complementary rather than direct competitors.

Choose HealthCCSng if…

Choose HealthCCSng if your primary goal is to proactively assess a patient's long-term risk for coronary artery disease using existing imaging data. This tool is ideal for leveraging routine non-contrast chest CT scans to automatically detect, quantify, and categorize coronary artery calcification, providing valuable insights into cardiovascular risk without requiring additional dedicated scans.

View HealthCCSng →

Choose Zio XT ECG Monitoring System if…

Choose the Zio XT ECG Monitoring System if you need to diagnose or rule out intermittent cardiac arrhythmias over an extended period. This wearable, continuous monitoring solution is perfect for patients experiencing symptoms like palpitations or syncope, allowing for up to 14 days of comfortable, lead-free ECG recording and AI-powered analysis to capture elusive cardiac events.

View Zio XT ECG Monitoring System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	HealthCCSng	Zio XT ECG Monitoring System
Pricing	Not publicly available	Contact for pricing
Deployment	Cloud-based, integrates with PACS and EMR systems	Cloud-based (AWS EC2 platform), no on-premise hardware required.
BAA Available	Unknown	Yes AI-estimated
FDA Status	Yes AI-estimated	Yes AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

HealthCCSng

HealthCCSng (Tool A) offers superior clinician usability by seamlessly integrating with existing PACS and EMR systems and providing an automated workflow for results without human intervention. This minimizes disruption to clinical practice and streamlines the process of obtaining critical diagnostic information.

Clinical Value

Tie

Both tools provide significant and distinct clinical value by leveraging FDA-cleared AI to address critical aspects of cardiac health. HealthCCSng focuses on identifying patients at risk of coronary artery disease through CAC quantification, while Zio XT excels at accurate arrhythmia detection and diagnosis via continuous ECG monitoring.

Pricing & Value

Zio XT ECG Monitoring System

Zio XT (Tool B) offers greater transparency regarding its pricing structure, providing specific examples of costs in the UK and proposed Medicare rates in the US. In contrast, HealthCCSng (Tool A) states its pricing is not publicly available and requires contacting the vendor for details, offering less initial clarity on potential costs.

Enterprise Readiness

Tie

Both tools demonstrate strong enterprise readiness, being FDA-cleared, HIPAA compliant, and cloud-based. HealthCCSng integrates with PACS and EMR systems, while Zio XT operates on the AWS EC2 platform and explicitly states having a Business Associate Agreement (BAA).

Innovation

Tie

Both tools showcase significant innovation in their respective domains. HealthCCSng innovates by applying AI to routine CT scans for automated CAC detection, extracting new diagnostic value from existing data. Zio XT innovates with its long-term, comfortable wearable biosensor and AI-driven analysis for comprehensive arrhythmia detection, enhancing remote monitoring capabilities.

Support & Docs

Tie

Neither the provided structured facts nor readily available public information offer specific details regarding the support channels, documentation quality, or training programs for either HealthCCSng or Zio XT. Therefore, it is not possible to distinguish between the two on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	HealthCCSng	Zio XT ECG Monitoring System
Tool Name	HealthCCSng	Zio XT ECG Monitoring System
Company	Nano-X AI	iRhythm Technologies
Primary Function	Analyzes routine CT scans to detect and quantify coronary artery calcification (CAC).	Wearable, single-lead ECG biosensor for continuous cardiac monitoring and arrhythmia detection.
Core Technology/Input	AI-powered analysis of non-contrast, non-ECG gated chest CT scans	Wearable single-lead ECG biosensor with FDA-cleared deep-learned AI algorithm for ECG data analysis
Target Condition	Coronary artery disease (via CAC detection)	Arrhythmia detection and diagnosis
Key Differentiator	Automated detection and quantification of CAC from routine CT scans without human intervention.	Continuous ambulatory cardiac monitoring for up to 14 days with a water-resistant, leadless biosensor.

Videos

Demos, reviews, and walkthroughs featuring HealthCCSng and Zio XT ECG Monitoring System.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary clinical problem each tool aims to address?

HealthCCSng is designed to identify patients at risk of coronary artery disease by automatically detecting and quantifying coronary artery calcification (CAC) from routine CT scans. The Zio XT ECG Monitoring System focuses on the accurate detection and diagnosis of cardiac arrhythmias through continuous ECG monitoring.

What type of patient data does each tool analyze?

HealthCCSng analyzes routine non-contrast, non-ECG gated chest CT scans to assess coronary artery calcification. The Zio XT ECG Monitoring System utilizes data collected from a wearable single-lead ECG biosensor for continuous ambulatory cardiac monitoring.

What are the key outputs or results provided by each system to the physician?

HealthCCSng provides automatic detection and quantification of CAC, categorizes studies into 'zero', 'low', 'moderate', and 'severe' CAC categories, generates a numerical calcium score, and offers visualization of calcified plaques. The Zio XT system delivers accurate arrhythmia detection and diagnosis, supported by its proprietary AI algorithm and expert review, with data reporting through its cloud-based software platform.

What is the patient experience like for each tool?

For HealthCCSng, the patient experience is passive, as the tool analyzes existing CT scans without requiring additional patient interaction beyond the initial scan. With Zio XT, patients wear a water-resistant single-lead ECG biosensor for up to 14 days, allowing for normal daily activities, and can log symptomatic events with a patient-activated button.

Which medical specialties would primarily utilize each tool?

HealthCCSng is primarily intended for use by Cardiology and Radiology specialties. The Zio XT ECG Monitoring System is relevant for Cardiology, Emergency Medicine, and Internal Medicine specialties.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring HealthCCSng or Zio XT ECG Monitoring System

Backers

Who funded each tool's parent company.